Related Experiment Video

Updated: May 24, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Revising you the staging for pancreatic cancer in 2012

Muhammad Wasif Saif

    JOP : Journal of the Pancreas
    |March 13, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Orthotopic Resectional Mouse Model of Pancreatic Cancer
    07:17

    An Orthotopic Resectional Mouse Model of Pancreatic Cancer

    Published on: September 24, 2020

    Related Experiment Videos

    Last Updated: May 24, 2026

    Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
    07:08

    Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

    Published on: February 2, 2024

    An Orthotopic Resectional Mouse Model of Pancreatic Cancer
    07:17

    An Orthotopic Resectional Mouse Model of Pancreatic Cancer

    Published on: September 24, 2020

    Related Concept Videos

    Chronic Pancreatitis II: Collaborative Care01:29

    Chronic Pancreatitis II: Collaborative Care

    The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
    Assessment:

    Articles linked to this work by shared authors, journal, and citation graph.

    XPO1 inhibition enhances the efficacy and durability of RAS-targeted therapy in preclinical models of KRASG12D mutant pancreatic ductal adenocarcinoma.

    Cancer letters·2026

    Staged approach to overcome hyperbilirubinemia: tailored chemotherapy in liver metastases-a case report.

    Journal of gastrointestinal oncology·2026

    An overview of KRAS-targeting therapies for colorectal cancer in phase I and II development.

    Expert opinion on investigational drugs·2026

    PCNA Inhibition Enhances the Antitumor Activity of KRAS-Targeted Therapies in Pancreatic Cancer.

    bioRxiv : the preprint server for biology·2025

    Co-targeting KRAS and Exportin1 as an effective therapeutic strategy for KRASG12D mutant pancreatic ductal adenocarcinoma.

    bioRxiv : the preprint server for biology·2025

    An Update on Novel Pharmacotherapies for the Treatment of Neuroendocrine Tumors.

    International journal of molecular sciences·2025

    From Screening to Treatment of Pancreatic Cancer: A Comprehensive Review.

    JOP : Journal of the pancreas·2021

    Survival Benefits and Disparities in Adjuvant Radiation Therapy for Patients with Pancreatic Cancer.

    JOP : Journal of the pancreas·2021

    Is There any Survival Benefit of Maintenance Chemotherapy Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer Patients with Post-Surgery Elevated CA 19-9?

    JOP : Journal of the pancreas·2020

    New Developments in the Treatment of Pancreatic Cancer: Highlights from the 44th ASCO Annual Virtual Meeting, May 29-31, 2020.

    JOP : Journal of the pancreas·2020

    Management of Pancreatic Cancer During COVID-19 Pandemic: To Treat or Not to Treat?

    JOP : Journal of the pancreas·2020

    Simplified/Same Day(s)-GOLF as First-line Treatment of Metastatic Carcinoma of Unknown Primary (CUP), Suggestive of Pancreatobiliary Tumors.

    JOP : Journal of the pancreas·2020
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us